Cargando…
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878344/ https://www.ncbi.nlm.nih.gov/pubmed/33399002 http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16724 |
_version_ | 1783650326224568320 |
---|---|
author | Chappell, Mark C. Pirro, Nancy T. South, Andrew M. Gwathmey, TanYa M. |
author_facet | Chappell, Mark C. Pirro, Nancy T. South, Andrew M. Gwathmey, TanYa M. |
author_sort | Chappell, Mark C. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7878344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-78783442021-02-22 Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma Chappell, Mark C. Pirro, Nancy T. South, Andrew M. Gwathmey, TanYa M. Hypertension Research Letter Lippincott Williams & Wilkins 2021-01-05 2021-03-03 /pmc/articles/PMC7878344/ /pubmed/33399002 http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16724 Text en © 2021 American Heart Association, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Research Letter Chappell, Mark C. Pirro, Nancy T. South, Andrew M. Gwathmey, TanYa M. Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma |
title | Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma |
title_full | Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma |
title_fullStr | Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma |
title_full_unstemmed | Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma |
title_short | Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1–7) and Angiotensin II in Human Plasma |
title_sort | concerns on the specificity of commercial elisas for the measurement of angiotensin (1–7) and angiotensin ii in human plasma |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878344/ https://www.ncbi.nlm.nih.gov/pubmed/33399002 http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16724 |
work_keys_str_mv | AT chappellmarkc concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma AT pirronancyt concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma AT southandrewm concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma AT gwathmeytanyam concernsonthespecificityofcommercialelisasforthemeasurementofangiotensin17andangiotensiniiinhumanplasma |